Persistent itching affects approximately 20-30% of adults with diabetes — substantially higher than non-diabetic peers. Multiple causes contribute: dry skin (the most common, affecting 75% of adults with diabetes), peripheral neuropathy producing neuropathic itch, diabetic nephropathy with uremic itch in advanced kidney disease, fungal infections (Candida intertrigo, athlete’s foot), contact dermatitis from medications or device adhesives, medication side effects, and chronic liver disease secondary to diabetes (NAFLD). Treatment depends entirely on cause — moisturizing for dry skin, anti-neuropathic medications for nerve itch, antifungals for fungal infection, and addressing systemic causes for uremic or cholestatic itch. Persistent unexplained itching can signal serious underlying conditions including kidney failure or liver dysfunction; evaluation beyond moisturizing is appropriate for itching lasting more than 2 weeks despite basic skin care.
Causes of Itching in Diabetes
| Cause | Distinguishing features | Frequency |
|---|---|---|
| Dry skin (xerosis) | Scaly, rough skin; worse with bathing | Most common (75% of diabetes) |
| Peripheral neuropathy | Burning, tingling itch; stocking distribution | Common (30% of diabetes neuropathy) |
| Uremic itch (CKD) | Generalized; worse with advanced kidney disease | Common in advanced nephropathy |
| Fungal infections | Itch with rash; skin folds, feet | 2-3x more common in diabetes |
| Cholestatic itch (liver) | Generalized; sometimes worse on palms/soles | NAFLD common in T2D |
| Contact dermatitis | Localized to contact area | From insulin, CGM, devices, medications |
| Medication side effects | Recent medication start | Varies |
| Generalized pruritus | No clear rash; chronic | Some adults have unclear cause |
Treatment by Cause
- Dry skin: aggressive moisturizing with ceramide or urea-based products; mild non-soap cleansers; lukewarm water.
- Neuropathic itch: gabapentin, pregabalin, duloxetine, topical capsaicin.
- Uremic itch: UV phototherapy, gabapentin, optimization of dialysis/CKD care.
- Fungal infections: topical antifungals (clotrimazole, miconazole, terbinafine); oral antifungals for severe cases.
- Cholestatic itch: cholestyramine, rifampin, naltrexone; address underlying liver disease.
- Contact dermatitis: identify and remove allergen; topical corticosteroids.
- Generalized non-specific itch: oral antihistamines (hydroxyzine, cetirizine), topical pramoxine, menthol, camphor.
Topical Anti-Itch Options
- Pramoxine 1%: topical anesthetic; mild antipruritic.
- Menthol: cooling sensation; reduces itch perception.
- Camphor: similar cooling effect.
- Hydrocortisone 1% (OTC) or higher potency (Rx): for inflammation.
- Calamine: zinc-based; soothing.
- Capsaicin cream: for neuropathic itch; takes 2-4 weeks.
- Doxepin cream: for refractory itch (limited use due to sedation).
- Crisaborole, tacrolimus: for eczematous itch.
Oral Medications for Itch
- Sedating antihistamines (hydroxyzine, diphenhydramine): useful for nighttime itch; cause drowsiness.
- Non-sedating antihistamines (cetirizine, fexofenadine, loratadine): useful for daytime itch.
- Gabapentin or pregabalin: for neuropathic and uremic itch.
- Doxepin (low-dose): tricyclic with strong anti-histamine effect.
- Naltrexone (low-dose): for cholestatic itch.
- Rifampin: for cholestatic itch.
- SSRIs (sertraline): for psychogenic or chronic idiopathic itch.
When Itch Signals Serious Issues
- Persistent itching without rash lasting more than 2 weeks.
- Itching with fatigue, jaundice, or weight loss (suggests liver disease).
- Itching with edema, decreased urination (suggests advanced kidney disease).
- Itching with significant skin yellowing.
- Itching localized to one area with skin changes (suggests dermatitis).
- Itching worsening despite moisturizing and OTC treatments.
- Itching disrupting sleep (worsens A1C).
- Itching with diabetic foot wound (infection).
The Bottom Line
Persistent itching affects 20-30% of adults with diabetes — substantially higher than non-diabetic peers. Multiple causes contribute: dry skin (most common at 75% of adults with diabetes), peripheral neuropathy, diabetic nephropathy with uremic itch, fungal infections, contact dermatitis, medication side effects, and chronic liver disease (NAFLD common in T2D). Treatment depends entirely on cause — moisturizing for dry skin (the foundation for everyone), gabapentin/pregabalin for neuropathic itch, antifungals for fungal infection, addressing systemic causes for uremic or cholestatic itch. Topical options include pramoxine, menthol, camphor, hydrocortisone, and capsaicin. Oral antihistamines (sedating for night, non-sedating for day) provide adjunctive benefit. Persistent unexplained itching lasting more than 2 weeks despite moisturizing and basic care warrants evaluation — chronic itch can signal kidney failure, liver disease, or other serious conditions. Adults with diabetes have elevated rates of nephropathy and NAFLD, making this differential important. Improving glucose control often reduces itching through multiple pathways — better skin health, fewer fungal infections, slower progression of kidney and liver disease. For adults with diabetes experiencing persistent itch, comprehensive evaluation identifies treatable causes rather than just treating the symptom. See our broader dry skin and diabetes guide for context on the most common contributor.
